Industry Research Reports

Home > Reports > Medical Care > Global Vertebroplasty & Kyphoplasty Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Vertebroplasty & Kyphoplasty Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Medical Care

Published Date: 2025-09-06

Pages: 94 Pages

Report ld: 4990769

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Vertebroplasty & Kyphoplasty Market Size(US$)

CAGR 2025-2031

3.4%

Market Size,2031

USD 1,670

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 1,363 million

Market Forecast in 2031(Value)

US$ 1,670 million

CAGR

3.4%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Vertebroplasty & Kyphoplasty market size was US$ 1323 million in 2024 and is forecast to a readjusted size of US$ 1670 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.

Vertebroplasty & Kyphoplasty are minimally invasive, image guided surgical procedures performed to treat the Vertebral Compression Fracture (VCF). VCFs can lead to back pain, reduced physical activity, depression, loss of independence, decreased lung capacity, and difficulty sleeping. Bone cement is injected into the back bone (vertebra) to provide support to the broken bone. Due to osteoporosis, vascular malformatins or, less commonly, cancer fractures can be caused in the vertebra. Vertebroplasty & Kyphoplasty help the patient to regain the functional abilities and avoid further vertebral collapse. Kyphoplasty is an advanced version of Vertebroplasty which can stabilize the fracture, restore heights and reduce deformities. The report studies the vertebroplasty and kyphoplasty devices market.

Global Vertebroplasty and Kyphoplasty Devices key players include Medtronic, Stryker, J&J (Depuy Synthes), Globus Medical, Merit Medical, etc. Global top five manufacturers hold a share about 85%. North America is the largest market, with a share about 55%, followed by Asia-Pacific, with a share about 25 percent. In terms of product, Kyphoplasty is the largest segment, with a share about 80%. And in terms of application, the largest application is Hospital, followed by Ambulatory Surgery Center, etc.

The global Vertebroplasty & Kyphoplasty market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.

Market Segmentation

By Company

Depuy Synthes
Stryker Corporation
CareFusion Corporation
Osseon LLC.
Alphatec Spine, Inc.
TAEYEON MEDICAL Co., Ltd.
G-21 S.R.L
BMK Global Medical Company
Medtronic, Inc.,
Globus Medical, Inc
SOMATEX

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Vertebroplastic Device
Kyphoplastic Device

Segment by Application

Hospitals
Clinics
Others

biaoTi Chapter Outline

Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).

Chapter 2: Quantitative analysis of Vertebroplasty & Kyphoplasty market size and growth potential at global, regional, and country levels.

Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).

Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Kyphoplastic Device in China).

Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Clinics in India).

Chapter 6: Regional revenue breakdown by company, type, application and customer.

Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.

Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.

Chapter 9: Actionable conclusions and strategic recommendations.

biaoTi Why This Report?

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

Table of Contents

1 Report Overview

1.1 Study Scope

1.2 Market by Type

1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031

1.2.2 Vertebroplastic Device

1.2.3 Kyphoplastic Device

1.3 Market by Application

1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Vertebroplasty & Kyphoplasty Market Perspective (2020-2031)

2.2 Global Market Size by Region: 2020 VS 2024 VS 2031

2.3 Global Vertebroplasty & Kyphoplasty Revenue Market Share by Region (2020-2025)

2.4 Global Vertebroplasty & Kyphoplasty Revenue Forecast by Region (2026-2031)

2.5 Major Region and Emerging Market Analysis

2.5.1 North America Vertebroplasty & Kyphoplasty Market Size and Prospective (2020-2031)

2.5.2 Europe Vertebroplasty & Kyphoplasty Market Size and Prospective (2020-2031)

2.5.3 China Vertebroplasty & Kyphoplasty Market Size and Prospective (2020-2031)

2.5.4 Japan Vertebroplasty & Kyphoplasty Market Size and Prospective (2020-2031)

2.5.5 Southeast Asia Vertebroplasty & Kyphoplasty Market Size and Prospective (2020-2031)

2.5.6 India Vertebroplasty & Kyphoplasty Market Size and Prospective (2020-2031)

2.5.7 Central & South America Vertebroplasty & Kyphoplasty Market Size and Prospective (2020-2031)

3 Breakdown Data by Type

3.1 Global Vertebroplasty & Kyphoplasty Historic Market Size by Type (2020-2025)

3.2 Global Vertebroplasty & Kyphoplasty Forecasted Market Size by Type (2026-2031)

3.3 Different Types Vertebroplasty & Kyphoplasty Representative Players

4 Breakdown Data by Application

4.1 Global Vertebroplasty & Kyphoplasty Historic Market Size by Application (2020-2025)

4.2 Global Vertebroplasty & Kyphoplasty Forecasted Market Size by Application (2026-2031)

4.3 New Sources of Growth in Vertebroplasty & Kyphoplasty Application

5 Competition Landscape by Players

5.1 Global Top Players by Revenue

5.1.1 Global Top Vertebroplasty & Kyphoplasty Players by Revenue (2020-2025)

5.1.2 Global Vertebroplasty & Kyphoplasty Revenue Market Share by Players (2020-2025)

5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

5.3 Players Covered: Ranking by Vertebroplasty & Kyphoplasty Revenue

5.4 Global Vertebroplasty & Kyphoplasty Market Concentration Analysis

5.4.1 Global Vertebroplasty & Kyphoplasty Market Concentration Ratio (CR5 and HHI)

5.4.2 Global Top 10 and Top 5 Companies by Vertebroplasty & Kyphoplasty Revenue in 2024

5.5 Global Key Players of Vertebroplasty & Kyphoplasty Head office and Area Served

5.6 Global Key Players of Vertebroplasty & Kyphoplasty, Product and Application

5.7 Global Key Players of Vertebroplasty & Kyphoplasty, Date of Enter into This Industry

5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments and Downstream

6.1.1 North America Vertebroplasty & Kyphoplasty Revenue by Company (2020-2025)

6.1.2 North America Market Size by Type

6.1.2.1 North America Vertebroplasty & Kyphoplasty Market Size by Type (2020-2025)

6.1.2.2 North America Vertebroplasty & Kyphoplasty Market Share by Type (2020-2025)

6.1.3 North America Market Size by Application

6.1.3.1 North America Vertebroplasty & Kyphoplasty Market Size by Application (2020-2025)

6.1.3.2 North America Vertebroplasty & Kyphoplasty Market Share by Application (2020-2025)

6.1.4 North America Market Trend and Opportunities

6.2 Europe Market: Players, Segments and Downstream

6.2.1 Europe Vertebroplasty & Kyphoplasty Revenue by Company (2020-2025)

6.2.2 Europe Market Size by Type

6.2.2.1 Europe Vertebroplasty & Kyphoplasty Market Size by Type (2020-2025)

6.2.2.2 Europe Vertebroplasty & Kyphoplasty Market Share by Type (2020-2025)

6.2.3 Europe Market Size by Application

6.2.3.1 Europe Vertebroplasty & Kyphoplasty Market Size by Application (2020-2025)

6.2.3.2 Europe Vertebroplasty & Kyphoplasty Market Share by Application (2020-2025)

6.2.4 Europe Market Trend and Opportunities

6.3 China Market: Players, Segments and Downstream

6.3.1 China Vertebroplasty & Kyphoplasty Revenue by Company (2020-2025)

6.3.2 China Market Size by Type

6.3.2.1 China Vertebroplasty & Kyphoplasty Market Size by Type (2020-2025)

6.3.2.2 China Vertebroplasty & Kyphoplasty Market Share by Type (2020-2025)

6.3.3 China Market Size by Application

6.3.3.1 China Vertebroplasty & Kyphoplasty Market Size by Application (2020-2025)

6.3.3.2 China Vertebroplasty & Kyphoplasty Market Share by Application (2020-2025)

6.3.4 China Market Trend and Opportunities

6.4 Japan Market: Players, Segments and Downstream

6.4.1 Japan Vertebroplasty & Kyphoplasty Revenue by Company (2020-2025)

6.4.2 Japan Market Size by Type

6.4.2.1 Japan Vertebroplasty & Kyphoplasty Market Size by Type (2020-2025)

6.4.2.2 Japan Vertebroplasty & Kyphoplasty Market Share by Type (2020-2025)

6.4.3 Japan Market Size by Application

6.4.3.1 Japan Vertebroplasty & Kyphoplasty Market Size by Application (2020-2025)

6.4.3.2 Japan Vertebroplasty & Kyphoplasty Market Share by Application (2020-2025)

6.4.4 Japan Market Trend and Opportunities

6.5 Southeast Asia Market: Players, Segments and Downstream

6.5.1 Southeast Asia Vertebroplasty & Kyphoplasty Revenue by Company (2020-2025)

6.5.2 Southeast Asia Market Size by Type

6.5.2.1 Southeast Asia Vertebroplasty & Kyphoplasty Market Size by Type (2020-2025)

6.5.2.2 Southeast Asia Vertebroplasty & Kyphoplasty Market Share by Type (2020-2025)

6.5.3 Southeast Asia Market Size by Application

6.5.3.1 Southeast Asia Vertebroplasty & Kyphoplasty Market Size by Application (2020-2025)

6.5.3.2 Southeast Asia Vertebroplasty & Kyphoplasty Market Share by Application (2020-2025)

6.5.4 Southeast Asia Market Trend and Opportunities

6.6 India Market: Players, Segments and Downstream

6.6.1 India Vertebroplasty & Kyphoplasty Revenue by Company (2020-2025)

6.6.2 India Market Size by Type

6.6.2.1 India Vertebroplasty & Kyphoplasty Market Size by Type (2020-2025)

6.6.2.2 India Vertebroplasty & Kyphoplasty Market Share by Type (2020-2025)

6.6.3 India Market Size by Application

6.6.3.1 India Vertebroplasty & Kyphoplasty Market Size by Application (2020-2025)

6.6.3.2 India Vertebroplasty & Kyphoplasty Market Share by Application (2020-2025)

6.6.4 India Market Trend and Opportunities

7 Key Players Profiles

7.1 Depuy Synthes

7.1.1 Depuy Synthes Company Details

7.1.2 Depuy Synthes Business Overview

7.1.3 Depuy Synthes Vertebroplasty & Kyphoplasty Introduction

7.1.4 Depuy Synthes Revenue in Vertebroplasty & Kyphoplasty Business (2020-2025)

7.1.5 Depuy Synthes Recent Development

7.2 Stryker Corporation

7.2.1 Stryker Corporation Company Details

7.2.2 Stryker Corporation Business Overview

7.2.3 Stryker Corporation Vertebroplasty & Kyphoplasty Introduction

7.2.4 Stryker Corporation Revenue in Vertebroplasty & Kyphoplasty Business (2020-2025)

7.2.5 Stryker Corporation Recent Development

7.3 CareFusion Corporation

7.3.1 CareFusion Corporation Company Details

7.3.2 CareFusion Corporation Business Overview

7.3.3 CareFusion Corporation Vertebroplasty & Kyphoplasty Introduction

7.3.4 CareFusion Corporation Revenue in Vertebroplasty & Kyphoplasty Business (2020-2025)

7.3.5 CareFusion Corporation Recent Development

7.4 Osseon LLC.

7.4.1 Osseon LLC. Company Details

7.4.2 Osseon LLC. Business Overview

7.4.3 Osseon LLC. Vertebroplasty & Kyphoplasty Introduction

7.4.4 Osseon LLC. Revenue in Vertebroplasty & Kyphoplasty Business (2020-2025)

7.4.5 Osseon LLC. Recent Development

7.5 Alphatec Spine, Inc.

7.5.1 Alphatec Spine, Inc. Company Details

7.5.2 Alphatec Spine, Inc. Business Overview

7.5.3 Alphatec Spine, Inc. Vertebroplasty & Kyphoplasty Introduction

7.5.4 Alphatec Spine, Inc. Revenue in Vertebroplasty & Kyphoplasty Business (2020-2025)

7.5.5 Alphatec Spine, Inc. Recent Development

7.6 TAEYEON MEDICAL Co., Ltd.

7.6.1 TAEYEON MEDICAL Co., Ltd. Company Details

7.6.2 TAEYEON MEDICAL Co., Ltd. Business Overview

7.6.3 TAEYEON MEDICAL Co., Ltd. Vertebroplasty & Kyphoplasty Introduction

7.6.4 TAEYEON MEDICAL Co., Ltd. Revenue in Vertebroplasty & Kyphoplasty Business (2020-2025)

7.6.5 TAEYEON MEDICAL Co., Ltd. Recent Development

7.7 G-21 S.R.L

7.7.1 G-21 S.R.L Company Details

7.7.2 G-21 S.R.L Business Overview

7.7.3 G-21 S.R.L Vertebroplasty & Kyphoplasty Introduction

7.7.4 G-21 S.R.L Revenue in Vertebroplasty & Kyphoplasty Business (2020-2025)

7.7.5 G-21 S.R.L Recent Development

7.8 BMK Global Medical Company

7.8.1 BMK Global Medical Company Company Details

7.8.2 BMK Global Medical Company Business Overview

7.8.3 BMK Global Medical Company Vertebroplasty & Kyphoplasty Introduction

7.8.4 BMK Global Medical Company Revenue in Vertebroplasty & Kyphoplasty Business (2020-2025)

7.8.5 BMK Global Medical Company Recent Development

7.9 Medtronic, Inc.,

7.9.1 Medtronic, Inc., Company Details

7.9.2 Medtronic, Inc., Business Overview

7.9.3 Medtronic, Inc., Vertebroplasty & Kyphoplasty Introduction

7.9.4 Medtronic, Inc., Revenue in Vertebroplasty & Kyphoplasty Business (2020-2025)

7.9.5 Medtronic, Inc., Recent Development

7.10 Globus Medical, Inc

7.10.1 Globus Medical, Inc Company Details

7.10.2 Globus Medical, Inc Business Overview

7.10.3 Globus Medical, Inc Vertebroplasty & Kyphoplasty Introduction

7.10.4 Globus Medical, Inc Revenue in Vertebroplasty & Kyphoplasty Business (2020-2025)

7.10.5 Globus Medical, Inc Recent Development

7.11 SOMATEX

7.11.1 SOMATEX Company Details

7.11.2 SOMATEX Business Overview

7.11.3 SOMATEX Vertebroplasty & Kyphoplasty Introduction

7.11.4 SOMATEX Revenue in Vertebroplasty & Kyphoplasty Business (2020-2025)

7.11.5 SOMATEX Recent Development

8 Vertebroplasty & Kyphoplasty Market Dynamics

8.1 Vertebroplasty & Kyphoplasty Industry Trends

8.2 Vertebroplasty & Kyphoplasty Market Drivers

8.3 Vertebroplasty & Kyphoplasty Market Challenges

8.4 Vertebroplasty & Kyphoplasty Market Restraints

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

Table of Figures

List of Tables

Table 1. Global Vertebroplasty & Kyphoplasty Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Vertebroplasty & Kyphoplasty Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Market Vertebroplasty & Kyphoplasty Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Vertebroplasty & Kyphoplasty Revenue (US$ Million) Market Share by Region (2020-2025)

Table 5. Global Vertebroplasty & Kyphoplasty Revenue Share by Region (2020-2025)

Table 6. Global Vertebroplasty & Kyphoplasty Revenue (US$ Million) Forecast by Region (2026-2031)

Table 7. Global Vertebroplasty & Kyphoplasty Revenue Share Forecast by Region (2026-2031)

Table 8. Global Vertebroplasty & Kyphoplasty Market Size by Type (2020-2025) & (US$ Million)

Table 9. Global Vertebroplasty & Kyphoplasty Revenue Market Share by Type (2020-2025)

Table 10. Global Vertebroplasty & Kyphoplasty Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 11. Global Vertebroplasty & Kyphoplasty Revenue Market Share by Type (2026-2031)

Table 12. Representative Players of Each Type

Table 13. Global Vertebroplasty & Kyphoplasty Market Size by Application (2020-2025) & (US$ Million)

Table 14. Global Vertebroplasty & Kyphoplasty Revenue Market Share by Application (2020-2025)

Table 15. Global Vertebroplasty & Kyphoplasty Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 16. Global Vertebroplasty & Kyphoplasty Revenue Market Share by Application (2026-2031)

Table 17. New Sources of Growth in Vertebroplasty & Kyphoplasty Application

Table 18. Global Vertebroplasty & Kyphoplasty Revenue by Players (2020-2025) & (US$ Million)

Table 19. Global Vertebroplasty & Kyphoplasty Market Share by Players (2020-2025)

Table 20. Global Top Vertebroplasty & Kyphoplasty Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vertebroplasty & Kyphoplasty as of 2024)

Table 21. Ranking of Global Top Vertebroplasty & Kyphoplasty Companies by Revenue (US$ Million) in 2024

Table 22. Global 5 Largest Players Market Share by Vertebroplasty & Kyphoplasty Revenue (CR5 and HHI) & (2020-2025)

Table 23. Global Key Players of Vertebroplasty & Kyphoplasty, Headquarters and Area Served

Table 24. Global Key Players of Vertebroplasty & Kyphoplasty, Product and Application

Table 25. Global Key Players of Vertebroplasty & Kyphoplasty, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. North America Vertebroplasty & Kyphoplasty Revenue by Company (2020-2025) & (US$ Million)

Table 28. North America Vertebroplasty & Kyphoplasty Revenue Market Share by Company (2020-2025)

Table 29. North America Vertebroplasty & Kyphoplasty Market Size by Type (2020-2025) & (US$ Million)

Table 30. North America Vertebroplasty & Kyphoplasty Market Size by Application (2020-2025) & (US$ Million)

Table 31. Europe Vertebroplasty & Kyphoplasty Revenue by Company (2020-2025) & (US$ Million)

Table 32. Europe Vertebroplasty & Kyphoplasty Revenue Market Share by Company (2020-2025)

Table 33. Europe Vertebroplasty & Kyphoplasty Market Size by Type (2020-2025) & (US$ Million)

Table 34. Europe Vertebroplasty & Kyphoplasty Market Size by Application (2020-2025) & (US$ Million)

Table 35. China Vertebroplasty & Kyphoplasty Revenue by Company (2020-2025) & (US$ Million)

Table 36. China Vertebroplasty & Kyphoplasty Revenue Market Share by Company (2020-2025)

Table 37. China Vertebroplasty & Kyphoplasty Market Size by Type (2020-2025) & (US$ Million)

Table 38. China Vertebroplasty & Kyphoplasty Market Size by Application (2020-2025) & (US$ Million)

Table 39. Japan Vertebroplasty & Kyphoplasty Revenue by Company (2020-2025) & (US$ Million)

Table 40. Japan Vertebroplasty & Kyphoplasty Revenue Market Share by Company (2020-2025)

Table 41. Japan Vertebroplasty & Kyphoplasty Market Size by Type (2020-2025) & (US$ Million)

Table 42. Japan Vertebroplasty & Kyphoplasty Market Size by Application (2020-2025) & (US$ Million)

Table 43. Southeast Asia Vertebroplasty & Kyphoplasty Revenue by Company (2020-2025) & (US$ Million)

Table 44. Southeast Asia Vertebroplasty & Kyphoplasty Revenue Market Share by Company (2020-2025)

Table 45. Southeast Asia Vertebroplasty & Kyphoplasty Market Size by Type (2020-2025) & (US$ Million)

Table 46. Southeast Asia Vertebroplasty & Kyphoplasty Market Size by Application (2020-2025) & (US$ Million)

Table 47. India Vertebroplasty & Kyphoplasty Revenue by Company (2020-2025) & (US$ Million)

Table 48. India Vertebroplasty & Kyphoplasty Revenue Market Share by Company (2020-2025)

Table 49. India Vertebroplasty & Kyphoplasty Market Size by Type (2020-2025) & (US$ Million)

Table 50. India Vertebroplasty & Kyphoplasty Market Size by Application (2020-2025) & (US$ Million)

Table 51. Depuy Synthes Company Details

Table 52. Depuy Synthes Business Overview

Table 53. Depuy Synthes Vertebroplasty & Kyphoplasty Product

Table 54. Depuy Synthes Revenue in Vertebroplasty & Kyphoplasty Business (2020-2025) & (US$ Million)

Table 55. Depuy Synthes Recent Development

Table 56. Stryker Corporation Company Details

Table 57. Stryker Corporation Business Overview

Table 58. Stryker Corporation Vertebroplasty & Kyphoplasty Product

Table 59. Stryker Corporation Revenue in Vertebroplasty & Kyphoplasty Business (2020-2025) & (US$ Million)

Table 60. Stryker Corporation Recent Development

Table 61. CareFusion Corporation Company Details

Table 62. CareFusion Corporation Business Overview

Table 63. CareFusion Corporation Vertebroplasty & Kyphoplasty Product

Table 64. CareFusion Corporation Revenue in Vertebroplasty & Kyphoplasty Business (2020-2025) & (US$ Million)

Table 65. CareFusion Corporation Recent Development

Table 66. Osseon LLC. Company Details

Table 67. Osseon LLC. Business Overview

Table 68. Osseon LLC. Vertebroplasty & Kyphoplasty Product

Table 69. Osseon LLC. Revenue in Vertebroplasty & Kyphoplasty Business (2020-2025) & (US$ Million)

Table 70. Osseon LLC. Recent Development

Table 71. Alphatec Spine, Inc. Company Details

Table 72. Alphatec Spine, Inc. Business Overview

Table 73. Alphatec Spine, Inc. Vertebroplasty & Kyphoplasty Product

Table 74. Alphatec Spine, Inc. Revenue in Vertebroplasty & Kyphoplasty Business (2020-2025) & (US$ Million)

Table 75. Alphatec Spine, Inc. Recent Development

Table 76. TAEYEON MEDICAL Co., Ltd. Company Details

Table 77. TAEYEON MEDICAL Co., Ltd. Business Overview

Table 78. TAEYEON MEDICAL Co., Ltd. Vertebroplasty & Kyphoplasty Product

Table 79. TAEYEON MEDICAL Co., Ltd. Revenue in Vertebroplasty & Kyphoplasty Business (2020-2025) & (US$ Million)

Table 80. TAEYEON MEDICAL Co., Ltd. Recent Development

Table 81. G-21 S.R.L Company Details

Table 82. G-21 S.R.L Business Overview

Table 83. G-21 S.R.L Vertebroplasty & Kyphoplasty Product

Table 84. G-21 S.R.L Revenue in Vertebroplasty & Kyphoplasty Business (2020-2025) & (US$ Million)

Table 85. G-21 S.R.L Recent Development

Table 86. BMK Global Medical Company Company Details

Table 87. BMK Global Medical Company Business Overview

Table 88. BMK Global Medical Company Vertebroplasty & Kyphoplasty Product

Table 89. BMK Global Medical Company Revenue in Vertebroplasty & Kyphoplasty Business (2020-2025) & (US$ Million)

Table 90. BMK Global Medical Company Recent Development

Table 91. Medtronic, Inc., Company Details

Table 92. Medtronic, Inc., Business Overview

Table 93. Medtronic, Inc., Vertebroplasty & Kyphoplasty Product

Table 94. Medtronic, Inc., Revenue in Vertebroplasty & Kyphoplasty Business (2020-2025) & (US$ Million)

Table 95. Medtronic, Inc., Recent Development

Table 96. Globus Medical, Inc Company Details

Table 97. Globus Medical, Inc Business Overview

Table 98. Globus Medical, Inc Vertebroplasty & Kyphoplasty Product

Table 99. Globus Medical, Inc Revenue in Vertebroplasty & Kyphoplasty Business (2020-2025) & (US$ Million)

Table 100. Globus Medical, Inc Recent Development

Table 101. SOMATEX Company Details

Table 102. SOMATEX Business Overview

Table 103. SOMATEX Vertebroplasty & Kyphoplasty Product

Table 104. SOMATEX Revenue in Vertebroplasty & Kyphoplasty Business (2020-2025) & (US$ Million)

Table 105. SOMATEX Recent Development

Table 106. Vertebroplasty & Kyphoplasty Market Trends

Table 107. Vertebroplasty & Kyphoplasty Market Drivers

Table 108. Vertebroplasty & Kyphoplasty Market Challenges

Table 109. Vertebroplasty & Kyphoplasty Market Restraints

Table 110. Research Programs/Design for This Report

Table 111. Key Data Information from Secondary Sources

Table 112. Key Data Information from Primary Sources

List of Figures

Figure 1. Vertebroplasty & Kyphoplasty Product Picture

Figure 2. Global Vertebroplasty & Kyphoplasty Market Share by Type: 2024 VS 2031

Figure 3. Vertebroplastic Device Features

Figure 4. Kyphoplastic Device Features

Figure 5. Global Vertebroplasty & Kyphoplasty Market Share by Application: 2024 VS 2031

Figure 6. Hospitals

Figure 7. Clinics

Figure 8. Others

Figure 9. Vertebroplasty & Kyphoplasty Report Years Considered

Figure 10. Global Vertebroplasty & Kyphoplasty Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 11. Global Vertebroplasty & Kyphoplasty Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Vertebroplasty & Kyphoplasty Revenue Market Share by Region: 2020 VS 2024

Figure 13. North America Vertebroplasty & Kyphoplasty Revenue (US$ Million) Growth Rate (2020-2031)

Figure 14. Europe Vertebroplasty & Kyphoplasty Revenue (US$ Million) Growth Rate (2020-2031)

Figure 15. China Vertebroplasty & Kyphoplasty Revenue (US$ Million) Growth Rate (2020-2031)

Figure 16. Japan Vertebroplasty & Kyphoplasty Revenue (US$ Million) Growth Rate (2020-2031)

Figure 17. Southeast Asia Vertebroplasty & Kyphoplasty Revenue (US$ Million) Growth Rate (2020-2031)

Figure 18. India Vertebroplasty & Kyphoplasty Revenue (US$ Million) Growth Rate (2020-2031)

Figure 19. Central & South America Vertebroplasty & Kyphoplasty Revenue (US$ Million) Growth Rate (2020-2031)

Figure 20. Global Vertebroplasty & Kyphoplasty Market Share by Players in 2024

Figure 21. Global Top Vertebroplasty & Kyphoplasty Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vertebroplasty & Kyphoplasty as of 2024)

Figure 22. The Top 10 and 5 Players Market Share by Vertebroplasty & Kyphoplasty Revenue in 2024

Figure 23. North America Vertebroplasty & Kyphoplasty Market Share by Type (2020-2025)

Figure 24. North America Vertebroplasty & Kyphoplasty Market Share by Application (2020-2025)

Figure 25. Europe Vertebroplasty & Kyphoplasty Market Share by Type (2020-2025)

Figure 26. Europe Vertebroplasty & Kyphoplasty Market Share by Application (2020-2025)

Figure 27. China Vertebroplasty & Kyphoplasty Market Share by Type (2020-2025)

Figure 28. China Vertebroplasty & Kyphoplasty Market Share by Application (2020-2025)

Figure 29. Japan Vertebroplasty & Kyphoplasty Market Share by Type (2020-2025)

Figure 30. Japan Vertebroplasty & Kyphoplasty Market Share by Application (2020-2025)

Figure 31. Southeast Asia Vertebroplasty & Kyphoplasty Market Share by Type (2020-2025)

Figure 32. Southeast Asia Vertebroplasty & Kyphoplasty Market Share by Application (2020-2025)

Figure 33. India Vertebroplasty & Kyphoplasty Market Share by Type (2020-2025)

Figure 34. India Vertebroplasty & Kyphoplasty Market Share by Application (2020-2025)

Figure 35. Depuy Synthes Revenue Growth Rate in Vertebroplasty & Kyphoplasty Business (2020-2025)

Figure 36. Stryker Corporation Revenue Growth Rate in Vertebroplasty & Kyphoplasty Business (2020-2025)

Figure 37. CareFusion Corporation Revenue Growth Rate in Vertebroplasty & Kyphoplasty Business (2020-2025)

Figure 38. Osseon LLC. Revenue Growth Rate in Vertebroplasty & Kyphoplasty Business (2020-2025)

Figure 39. Alphatec Spine, Inc. Revenue Growth Rate in Vertebroplasty & Kyphoplasty Business (2020-2025)

Figure 40. TAEYEON MEDICAL Co., Ltd. Revenue Growth Rate in Vertebroplasty & Kyphoplasty Business (2020-2025)

Figure 41. G-21 S.R.L Revenue Growth Rate in Vertebroplasty & Kyphoplasty Business (2020-2025)

Figure 42. BMK Global Medical Company Revenue Growth Rate in Vertebroplasty & Kyphoplasty Business (2020-2025)

Figure 43. Medtronic, Inc., Revenue Growth Rate in Vertebroplasty & Kyphoplasty Business (2020-2025)

Figure 44. Globus Medical, Inc Revenue Growth Rate in Vertebroplasty & Kyphoplasty Business (2020-2025)

Figure 45. SOMATEX Revenue Growth Rate in Vertebroplasty & Kyphoplasty Business (2020-2025)

Figure 46. Bottom-up and Top-down Approaches for This Report

Figure 47. Data Triangulation

Figure 48. Key Executives Interviewed

Related Reports

Global Vertebroplasty & Kyphoplasty Market Research Report 2024
Vertebroplasty & Kyphoplasty are minimally invasive, image guided surgical procedures performed to treat the Vertebral Compression Fracture (VCF). VCFs can lead to back pain, reduced physical activity, depression, loss of independence, decreased lung capacity, and difficulty sleeping. Bone cement is injected into the back bone (vertebra) to provide support to the broken bone. Due to osteoporosis, vascular malformatins or, less commonly, cancer fractures can be caused in the vertebra. Vertebroplasty & Kyphoplasty help the patient to regain the functional abilities and avoid further vertebral collapse. Kyphoplasty is an advanced version of Vertebroplasty which can stabilize the fracture, restore heights and reduce deformities. The report studies the vertebroplasty and kyphoplasty devices market.
Published Date: 2024-01-16
Pages: 88
USD 2900.00
(Single User License)
Vertebroplasty & Kyphoplasty - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Vertebroplasty & Kyphoplasty are minimally invasive, image guided surgical procedures performed to treat the Vertebral Compression Fracture (VCF). VCFs can lead to back pain, reduced physical activity, depression, loss of independence, decreased lung capacity, and difficulty sleeping. Bone cement is injected into the back bone (vertebra) to provide support to the broken bone. Due to osteoporosis, vascular malformatins or, less commonly, cancer fractures can be caused in the vertebra. Vertebroplasty & Kyphoplasty help the patient to regain the functional abilities and avoid further vertebral collapse. Kyphoplasty is an advanced version of Vertebroplasty which can stabilize the fracture, restore heights and reduce deformities. The report studies the vertebroplasty and kyphoplasty devices market.
Published Date: 2024-01-24
Pages: 110
USD 3950.00
(Single User License)
Global Vertebroplasty & Kyphoplasty Market Insights, Forecast to 2030
Vertebroplasty & Kyphoplasty are minimally invasive, image guided surgical procedures performed to treat the Vertebral Compression Fracture (VCF). VCFs can lead to back pain, reduced physical activity, depression, loss of independence, decreased lung capacity, and difficulty sleeping. Bone cement is injected into the back bone (vertebra) to provide support to the broken bone. Due to osteoporosis, vascular malformatins or, less commonly, cancer fractures can be caused in the vertebra. Vertebroplasty & Kyphoplasty help the patient to regain the functional abilities and avoid further vertebral collapse. Kyphoplasty is an advanced version of Vertebroplasty which can stabilize the fracture, restore heights and reduce deformities. The report studies the vertebroplasty and kyphoplasty devices market.
Published Date: 2024-04-12
Pages: 108
USD 4900.00
(Single User License)
Global Vertebroplasty & Kyphoplasty Market Research Report 2025
The global market for Vertebroplasty & Kyphoplasty was valued at US$ 1323 million in the year 2024 and is projected to reach a revised size of US$ 1670 million by 2031, growing at a CAGR of 3.4% during the forecast period.
Published Date: 2025-02-27
Pages: 81
USD 2900.00
(Single User License)
Vertebroplasty & Kyphoplasty- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Vertebroplasty & Kyphoplasty was estimated to be worth US$ 1323 million in 2024 and is forecast to a readjusted size of US$ 1670 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.
Published Date: 2025-02-27
Pages: 111
USD 3950.00
(Single User License)
Global Vertebroplasty & Kyphoplasty Market Research Report 2026
The global Vertebroplasty & Kyphoplasty market was valued at US$ 1363 million in 2025 and is anticipated to reach US$ 1722 million by 2032, at a CAGR of 3.4% from 2026 to 2032.
Published Date: 2026-04-27
Pages: 117
USD 2900.00
(Single User License)
Vertebroplasty & Kyphoplasty - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Vertebroplasty & Kyphoplasty was estimated to be worth US$ 1363 million in 2025 and is projected to reach US$ 1722 million, growing at a CAGR of 3.4% from 2026 to 2032.
Published Date: 2026-07-14
Pages: 120
USD 3950.00
(Single User License)

Global Vertebroplasty & Kyphoplasty Market Research Report 2024
Vertebroplasty & Kyphoplasty are minimally invasive, image guided surgical procedures performed to treat the Vertebral Compression Fracture (VCF). VCFs can lead to back pain, reduced physical activity, depression, loss of independence, decreased lung capacity, and difficulty sleeping. Bone cement is injected into the back bone (vertebra) to provide support to the broken bone. Due to osteoporosis, vascular malformatins or, less commonly, cancer fractures can be caused in the vertebra. Vertebroplasty & Kyphoplasty help the patient to regain the functional abilities and avoid further vertebral collapse. Kyphoplasty is an advanced version of Vertebroplasty which can stabilize the fracture, restore heights and reduce deformities. The report studies the vertebroplasty and kyphoplasty devices market.
Published: 2024-01-16
Pages: 88
USD 2900.00 (Single User License)
Vertebroplasty & Kyphoplasty - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Vertebroplasty & Kyphoplasty are minimally invasive, image guided surgical procedures performed to treat the Vertebral Compression Fracture (VCF). VCFs can lead to back pain, reduced physical activity, depression, loss of independence, decreased lung capacity, and difficulty sleeping. Bone cement is injected into the back bone (vertebra) to provide support to the broken bone. Due to osteoporosis, vascular malformatins or, less commonly, cancer fractures can be caused in the vertebra. Vertebroplasty & Kyphoplasty help the patient to regain the functional abilities and avoid further vertebral collapse. Kyphoplasty is an advanced version of Vertebroplasty which can stabilize the fracture, restore heights and reduce deformities. The report studies the vertebroplasty and kyphoplasty devices market.
Published: 2024-01-24
Pages: 110
USD 3950.00 (Single User License)
Global Vertebroplasty & Kyphoplasty Market Insights, Forecast to 2030
Vertebroplasty & Kyphoplasty are minimally invasive, image guided surgical procedures performed to treat the Vertebral Compression Fracture (VCF). VCFs can lead to back pain, reduced physical activity, depression, loss of independence, decreased lung capacity, and difficulty sleeping. Bone cement is injected into the back bone (vertebra) to provide support to the broken bone. Due to osteoporosis, vascular malformatins or, less commonly, cancer fractures can be caused in the vertebra. Vertebroplasty & Kyphoplasty help the patient to regain the functional abilities and avoid further vertebral collapse. Kyphoplasty is an advanced version of Vertebroplasty which can stabilize the fracture, restore heights and reduce deformities. The report studies the vertebroplasty and kyphoplasty devices market.
Published: 2024-04-12
Pages: 108
USD 4900.00 (Single User License)
Global Vertebroplasty & Kyphoplasty Market Research Report 2025
The global market for Vertebroplasty & Kyphoplasty was valued at US$ 1323 million in the year 2024 and is projected to reach a revised size of US$ 1670 million by 2031, growing at a CAGR of 3.4% during the forecast period.
Published: 2025-02-27
Pages: 81
USD 2900.00 (Single User License)
Vertebroplasty & Kyphoplasty- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Vertebroplasty & Kyphoplasty was estimated to be worth US$ 1323 million in 2024 and is forecast to a readjusted size of US$ 1670 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.
Published: 2025-02-27
Pages: 111
USD 3950.00 (Single User License)
Global Vertebroplasty & Kyphoplasty Market Research Report 2026
The global Vertebroplasty & Kyphoplasty market was valued at US$ 1363 million in 2025 and is anticipated to reach US$ 1722 million by 2032, at a CAGR of 3.4% from 2026 to 2032.
Published: 2026-04-27
Pages: 117
USD 2900.00 (Single User License)
Vertebroplasty & Kyphoplasty - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Vertebroplasty & Kyphoplasty was estimated to be worth US$ 1363 million in 2025 and is projected to reach US$ 1722 million, growing at a CAGR of 3.4% from 2026 to 2032.
Published: 2026-07-14
Pages: 120
USD 3950.00 (Single User License)